Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dexibuprofen 300mg tablets
1001010AMAAAAAA
|
Dexibuprofen | Dexibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Dexibuprofen 400mg tablets
1001010AMAAABAB
|
Dexibuprofen | Dexibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Dexmethylphenidate 10mg modified-release capsules
0404000T0AAAAAA
|
Dexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride | Central Nervous System | No data available |
|
Dexomon 75mg SR tablets
1001010C0BUABAL
|
Dexomon | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Dexrazoxane 500mg powder for solution for infusion vials
0801000Y0AAAAAA
|
Dexrazoxane | Dexrazoxane | Malignant Disease and Immunosuppression | No data available |
|
Dextromethorphan 10mg/5ml /Pseudoephedrine 10mg/5ml susp SF
0309020R0AAACAC
|
Dextromethorphan hydrobromide compound preparations | Dextromethorphan hydrobrom compound prepartions | Respiratory System | No data available |
|
Dextromethorphan 10mg/5ml oral suspension
0309010L0AAAMAM
|
Dextromethorphan hydrobromide | Dextromethorphan hydrobromide | Respiratory System | No data available |
|
Dextromethorphan 2.5mg lozenges
0309010L0AAADAD
|
Dextromethorphan hydrobromide | Dextromethorphan hydrobromide | Respiratory System | No data available |
|
Dextromethorphan 20mg/5ml oral liquid
0309010L0AAAIAI
|
Dextromethorphan hydrobromide | Dextromethorphan hydrobromide | Respiratory System | No data available |
|
Dextromethorphan 3.75mg/5ml oral solution sugar free
0309010L0AAAUAU
|
Dextromethorphan hydrobromide | Dextromethorphan hydrobromide | Respiratory System | No data available |
|
Dextromethorphan 30mg/5ml oral solution
0309010L0AAAXAX
|
Dextromethorphan hydrobromide | Dextromethorphan hydrobromide | Respiratory System | No data available |
|
Dextromethorphan 40.5mg/5ml oral liquid
0309010L0AAALAL
|
Dextromethorphan hydrobromide | Dextromethorphan hydrobromide | Respiratory System | No data available |
|
Dextromethorphan 5mg / Triprolidine 625microg/5ml soln SF
0309010L0AAANAN
|
Dextromethorphan hydrobromide | Dextromethorphan hydrobromide | Respiratory System | No data available |
|
Dextromethorphan 5mg/5ml oral solution sugar free
0309010L0AAARAR
|
Dextromethorphan hydrobromide | Dextromethorphan hydrobromide | Respiratory System | No data available |
|
Dextromethorphan 7.5mg pastilles sugar free
0309010L0AAASAS
|
Dextromethorphan hydrobromide | Dextromethorphan hydrobromide | Respiratory System | No data available |
|
Dextromethorphan 7.5mg/5ml oral solution
0309010L0AAATAT
|
Dextromethorphan hydrobromide | Dextromethorphan hydrobromide | Respiratory System | No data available |
|
Dextromoramide 10mg tablets
0407020D0AAAEAE
|
Dextromoramide tartrate | Dextromoramide tartrate | Central Nervous System | No data available |
|
Dextromoramide 5mg tablets
0407020D0AAADAD
|
Dextromoramide tartrate | Dextromoramide tartrate | Central Nervous System | No data available |
|
Dextropropoxyphene 60mg capsules
0407020E0AAAAAA
|
Dextropropoxyphene | Dextropropoxyphene | Central Nervous System | No data available |
|
DHEA 10mg tablets
0604030Q0BBAGAH
|
DHEA | Prasterone | Endocrine System | No data available |
|
Diabetamide 2.5mg tablets
0601021H0BKAAAA
|
Diabetamide | Glibenclamide | Endocrine System | No data available |
|
Diabetamide 5mg tablets
0601021H0BKABAB
|
Diabetamide | Glibenclamide | Endocrine System | No data available |
|
Diabiom 15mg tablets
0601023B0BEAAAA
|
Diabiom | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Diabiom 30mg tablets
0601023B0BEABAB
|
Diabiom | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Diabiom 45mg tablets
0601023B0BEACAC
|
Diabiom | Pioglitazone hydrochloride | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.